Please assess the completion status of the following clinical trial:

Trial Title: Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients (SETH2)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* men aged \> 35 years~* body mass index \> 30 kg/m2~* confirmed hypogonadism~* type 2 diabetes mellitus treated with non-insulin therapy~Exclusion Criteria:~* previously treated hypogonadism~* the 2 diabetes mellitus treated with insulin therapy~* a history of current prostate or breast cancer~* severe benign prostatic hyperplasia~* elevated prostate-specific antigen (PSA \> 4.0 lg/l)~* severe heart failure~* acute coronary event or procedure during the six months leading up to the study~* chronic obstructive lung disease~* hypothyroidism~* severe obstructive sleep apnea (OSA)~* active infection~* rheumatoid arthritis

- Gender: MALE
- Minimum Age: 35 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Testosterone (Type: ACTIVE_COMPARATOR): Testosterone arm patients were receiving testosterone undecanoate 1000 mg intramuscular injections two years; according to the protocol every 10 weeks
- Placebo (Type: PLACEBO_COMPARATOR): Placebo arm patients were receiving placebo throughout the first year of this study and testosterone undecanoate 1000 mg intramuscular injections during second year.

Based on this trial design, predict the completion outcome and termination type (if applicable).